Thermo Fisher Scientific Showcases Global Innovation at DCAT Week 2022
As part of the annual Drug, Chemical & Associated Technologies Association (DCAT) conference, Thermo Fisher highlighted upcoming investments and innovation happening across its global pharma services network. From development to commercial, these investments provide integrated solutions that simplify the supply chain and accelerate the pace of development, enhancing productivity for customers. These investments focus on expanding key pharma services capabilities, including cell and gene therapies, early-stage process development, steriles and biologics growth, and digital transformation of the supply chain.
Learn More »
Thermo Fisher Scientific recognized with six CMO Leadership Awards
Thermo Fisher Scientific is proud to announce it has won six awards in the 11th annual CMO Leadership Awards. The awards, presented by Life Science Leader and Outsourced Pharma, recognize top contract manufacturing partners as evaluated by biopharma and biotech companies. Thermo Fisher won across all six categories, including: Capabilities, Compatibility, Expertise, Quality, Reliability and Service. This is the third consecutive year Thermo Fisher has received this recognition across all six categories and ninth time overall that the company has been honored by the CMO Leadership Awards.
Learn More »
Thermo Fisher Introduces New Cell and Gene Therapy Integrated Commercial Packaging and Distribution Services
Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific designed to seamlessly transition therapies from clinic to commercial launch for patients across the U.S. and Europe. The Patheon Commercial Packaging Services for Cell and Gene Therapies (CGT) is an end-to-end solution combining the GMP storage, serialization, ultracold and cryogenic packaging, and global distribution developers need to support their logistics strategies.
Learn More »
Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland
As part of its strategic partnership with CSL Limited, Thermo Fisher announced that it has assumed operational responsibility for a new 1.5-million-square-foot biologics manufacturing site in Lengnau, Switzerland. The site will become part of Thermo Fisher’s global biologics manufacturing network and will leverage highly flexible bioproduction technologies, including both single-use and stainless steel with up to 12,500L bioreactor capacity.
Learn More »
IndustryWeek Best Plants Award Winner 2021
Our Greenville, NC manufacturing site is a recipient of a 2021 IndustryWeek Best Plants Award, which recognizes North American manufacturing facilities for excellence across a range of factors, including productivity, customer care and employee engagement. This is the fourth IndustryWeek Best Plants Award for the company, which previously received the award for its sites in Auburn, Ala.; Asheville, N.C.; and Marietta, Ohio.
Learn More »
